The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Protection against β‐amyloid peptide toxicity in vivo with long‐term administration of ferulic acid
Open accessAbstract
β‐Amyloid peptide (Aβ), a 39 – 43 amino acid peptide, is believed to induce oxidative stress and inflammation in the brain, which are postulated to play important roles in the pathogenesis of Alzheimer's disease. Ferulic acid is an antioxidant and anti‐inflammatory agent derived from plants; therefore, the potential protective activity of ferulic acid against Aβ toxicity in vivo was examined. Mice were allowed free access to drinking water (control) or water containing ferulic acid (0.006%). After 4 weeks, Aβ1‐42 (410 pmol) was administered via intracerebroventricular injection. Injection of control mice with Aβ1‐42 impaired performance on the passive avoidance test (35% decrease in step‐through latency), the Y‐maze test (19% decrease in alternation behaviour), and the water maze test (32% decrease in percentage time in platform‐quadrant). In contrast, mice treated with ferulic acid prior to Aβ1‐42 administration were protected from these changes (9% decrease in step‐through latency; no decrease in alternation behaviour; 14% decrease in percentage time in platform‐quadrant). Aβ1‐42 induced 31% decrease in acetylcholine level in the cortex, which was tended to be ameliorated by ferulic acid. In addition, Aβ1‐42 increased immunoreactivities of the astrocyte marker glial fibrillary acidic protein (GFAP) and interleukin‐1β (IL‐1β) in the hippocampus, effects also suppressed by pretreatment with ferulic acid. Administration of ferulic acid per se unexpectedly induced a transient and slight increase in GFAP and IL‐1β immunoreactivity in the hippocampus on day 14, which returned to basal levels on day 28. A slight (8%) decrease in alternation behaviour was observed on day 14. These results demonstrate that long‐term administration of ferulic acid induces resistance to Aβ1‐42 toxicity in the brain, and suggest that ferulic acid may be a useful chemopreventive agent against Alzheimer's disease. British Journal of Pharmacology (2001) 133, 89–96; doi:10.1038/sj.bjp.0704047
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Antioxidant potential of ferulic acid
Graf, E. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90184-i · Cited by 1,115
‘Ischemic tolerance’ phenomenon found in the brain
Kitagawa, K., Matsumoto, M., Tagaya, M., Hata, R., Ueda, H., Niinobe, M., Handa, N., Fukunaga, R., Kimura, K., Mikoshiba, K., et al. (1990) · Brain Research · doi:10.1016/0006-8993(90)90189-i · Cited by 1,091
Clinical trial of indomethacin in Alzheimer's disease
Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1609 · Cited by 999
Huang, M., Smart, R. C., Wong, C.-Q., & Conney, A. H. (1988) · PubMed · Cited by 729
Vitamin E protects nerve cells from amyloid βprotein toxicity
Behl, C., Davis, J., Cole, G. M., & Schubert, D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90837-b · Cited by 581
Sarter, M., Bodewitz, G., & Stephens, D. N. (1988) · Psychopharmacology · doi:10.1007/bf00212843 · Cited by 530
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 521
Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches
Behl, C. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00055-0 · Cited by 445
Cunningham, A. J., Murray, C. A., O'Neill, L. A. J., Lynch, M. A., & O'Connor, J. J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12252-4 · Cited by 433
Intracerebroventricular injections in mice
Laursen, S. E., & Belknap, J. K. (1986) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(86)90038-0 · Cited by 391
Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus
Bellinger, F. P., Madamba, S., & Siggins, G. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90959-q · Cited by 386
Murray, C. A., & Lynch, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02974.1998 · Cited by 359
Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
Katsuki, H., Nakai, S., Hirai, Y., Akaji, K.-I., Kiso, Y., & Satoh, M. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90099-r · Cited by 331
Amyloid Fibrils Activate Tyrosine Kinase-Dependent Signaling and Superoxide Production in Microglia
McDonald, D. R., Brunden, K. R., & Landreth, G. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02284.1997 · Cited by 317
Araujo, D. M., & Cotman, C. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)90380-r · Cited by 295
Tasaki, K., Ruetzler, C. A., Ohtsuki, T., Martin, D., Nawashiro, H., & Hallenbeck, J. M. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01383-2 · Cited by 281
β-Amyloid protein-induced Alzheimer's disease animal model
Nitta, A., Itoh, A., Hasegawa, T., & Nabeshima, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90239-9 · Cited by 266
Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat
Chopp, M., Chen, H., Ho, K.-L., Dereski, M. O., Brown, E., Hetzel, F. W., & Welch, K. M. A. (1989) · Neurology · doi:10.1212/wnl.39.10.1396 · Cited by 264
Spreading Depression Induces Tolerance of Cortical Neurons to Ischemia in Rat Brain
Kobayashi, S., Harris, V. A., & Welsh, F. A. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.92 · Cited by 263
Yamada, K., Tanaka, T., Han, D., Senzaki, K., Kameyama, T., & Nabeshima, T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00408.x · Cited by 238
Evaluation of the Antioxidant Actions of Ferulic Acid and Catechins
Scott, B. C., Butler, J., Halliwell, B., & Aruoma, O. I. (1993) · Free Radical Research Communications · doi:10.3109/10715769309056512 · Cited by 223
Inflammation of the brain in Alzheimer's disease: implications for therapy
McGeer, P. L., & McGeer, E. G. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.409 · Cited by 220
Gitter, B. D., Cox, L. M., Rydel, R. E., & May, P. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10738 · Cited by 178
Flood, J. F., Morley, J. E., & Roberts, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3363 · Cited by 164
Anti-inflammatory Activity in Rats and Mice of Phenolic Acids Isolated from Scrophularia frutescens
Fernández, Á., Sáenz, M. T., & García, M. D. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb03332.x · Cited by 153
Hyperthermia-Induced Neuronal Protection against Ischemic Injury in Gerbils
Kitagawa, K., Matsumoto, M., Tagaya, M., Kuwabara, K., Hata, R., Handa, N., Fukunaga, R., Kimura, K., & Kamada, T. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.86 · Cited by 151
Nitta, A., Fukuta, T., Hasegawa, T., & Nabeshima, T. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.73.51 · Cited by 142
Olfactory afferent regulation of the dopamine phenotype in the fetal rat olfactory system
Baker, H. A., & Farbman, A. I. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90187-k · Cited by 113
Onozuka, M., Watanabe, K., Nagasaki, S., Jiang, Y., Ozono, S., Nishiyama, K., Kawase, T., Karasawa, N., & Nagatsu, I. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00145-x · Cited by 111
p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons
Enokido, Y., Araki, T., Aizawa, S., & Hatanaka, H. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12247-8 · Cited by 111
Antiinflammatory Effects of Tetramethylpyrazine and Ferulic Acid.
OZAKI, Y. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.954 · Cited by 109 · cited 2×
“Ferulic acid (4-hydroxy-3-methoxycinnamic acid), a phenolic compound present in a variety of plants, has potent antioxidant (Graf, 1992; Scott et al., 1993) and anti- in¯ammatory activities (Fernandez et al., 1998; Ozaki, 1992).”
BackgroundMatsushima, K., Schmidt‐Kastner, R., Hogan, M. J., & Hakim, A. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00716-1 · Cited by 109
Kawahara, N., Ruetzler, C. A., & KLATZO, I. (1995) · Neurological Research · doi:10.1080/01616412.1995.11740281 · Cited by 109
Hirabayashi, T., Ochiai, H., Sakai, S., Nakajima, K., & TERASAWA, K. (1995) · Planta Medica · doi:10.1055/s-2006-958060 · Cited by 103
Memory Impairment and Neuronal Dysfunction Induced by .BETA.-Amyloid Protein in Rats.
Nabeshima, T., & Nitta, A. (1994) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.174.241 · Cited by 100
Astroglial and microglial reactions in the gerbil hippocampus with induced ischemic tolerance
Kato, H., Kogure, K., Araki, T., & Itoyama, Y. (1994) · Brain Research · doi:10.1016/0006-8993(94)91955-0 · Cited by 83
Zheng, R., & Zhang, H. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00272-9 · Cited by 81
Anti-inflammatory action of ferulic acid and its esters in carrageenan induced rat paw oedema model.
Chawla, A. S., Singh, M. P., Murthy, M. S., Gupta, M., & Singh, H. (1987) · PubMed · Cited by 52
Cited by
Dietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
A review on cholinesterase inhibitors for Alzheimer’s disease
Anand, P., & Singh, B. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0036-3 · Cited by 709
Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: A review
Zhao, Z., & Moghadasian, M. H. (2008) · Food Chemistry · doi:10.1016/j.foodchem.2008.02.039 · Cited by 617
Ferulic acid: Pharmacological and toxicological aspects
Mancuso, C., & Santangelo, R. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.024 · Cited by 572
Metadata
- Authors
- Yan, J., Cho, J., Kim, H., Kim, K., Jung, J., Huh, S., Suh, H., Kim, Y., & Song, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2001-05
- Volume
- 133
- Issue
- 1
- Pages
- 89-96
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2037380525
- Cited by
- 364
- References
- 42
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.